Our Mission
Our mission is to advance the fight against cancer and other debilitating diseases by harnessing cutting-edge technologies to enhance early detection, improve diagnostics and treatment outcomes, and empower patients.
We strive to collaborate with each country worldwide, fostering a future where every individual has access to the most effective and personalised care.
Together, we aim to redefine the possibilities of medical and Artificial Intelligence and technological sciences combined, turning hope into reality for millions of affected by illness.
To accomplish our global mission, we have gathered world leading scientists within different disciplines from pathology, oncology, genomics to immunology, and mathematics to artificial intelligence. Combined with global expertise of over 40 years of research and development of combining all the scientific disciplines to create revolutionary science to aid humanity and drive medical, AI and technological sciences to develop our four pillars.
prevention: increased awareness, lifestyle choices.
diagnostics: patient grouping and individualised medicine, spatial biomarker assay design, single-cell transcriptomics, early detection.
prognostics: expression trajectory simulation and analysis, probabilistic reasoning.
treatment: precision medicine, targeted treatments that minimise adverse effects (toxicity) and maximise survival.
With dedication on our four pillars will enable following healthcare outcomes:
Diagnosing disease more accurately
Designing personalised cancer therapies
Reducing short-term treatment toxicities as well as long-term side effects
Anticipating and treating cancer relapse more effectively
Enhancing patients’ quality of life during and after treatment
Accelerating the recovery of cancer patients and enable them to resume a better quality of life
Identifying high-value drug targets for pharma industry that avoid development attrition.